Sectors
TGTX
TG Therapeutics, Inc.
54.30
1 x 46.67
1 x 61.42
bid
ask
+
0.37
0.69%
1 @ 04:23 PM
54.25 -0.05 (0.09%)
| Ytd | 82.15% | |
| 1y | 85.13% |
52.67
day range
54.36
26.76
52 week range
59.30
| Open | 53.58 | Prev Close | 53.93 | Low | 52.67 | High | 54.36 | Mkt Cap | 8.31B |
| Vol | 1.59M | Avg Vol | 2.46M | EPS | 2.74 | P/E | 19.82 | Forward P/E | 18.31 |
| Beta | 1.67 | Short Ratio | 13.30 | Inst. Own | 74.15% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-02 | 50-d Avg | 53.37 | 200-d Avg | 38.39 | 1yr Est | 69.71 |
| Income Statement | |||
| Total Revenue | 240.34M | ||
| Revenues (USD) | 240.34M | ||
| Cost of Revenue | 41.19M | ||
| Gross Profit | 199.14M | ||
| Operating Expenses | 177.47M | ||
| Research and Development Expense | 95.34M | ||
| Selling, General and Administrative Expense | 82.13M | ||
| Operating Income | 21.67M | ||
| Interest Expense | 16.57M | ||
| Income Tax Expense | 2.45M | ||
| Net Income | 7.78M | ||
| Net Income Common Stock | 7.78M | ||
| Net Income Common Stock (USD) | 7.78M | ||
| Consolidated Income | 7.78M | ||
| Earnings per Basic Share | 0.05 | ||
| Earnings per Basic Share (USD) | 0.05 | ||
| Earnings per Diluted Share | 0.05 | ||
| Earning Before Interest & Taxes (EBIT) | 26.81M | ||
| Earning Before Interest & Taxes (USD) | 26.81M | ||
| Weighted Average Shares | 141.77M | ||
| Weighted Average Shares Diluted | 157.28M | ||
| Balance Sheet | |||
| Cash and Equivalents | 483.94M | ||
| Cash and Equivalents (USD) | 483.94M | ||
| Investments | 134.04M | ||
| Investments Current | 69.67M | ||
| Investments Non-Current | 64.37M | ||
| Trade and Non-Trade Receivables | 401.57M | ||
| Current Assets | 1.15B | ||
| Property, Plant & Equipment Net | 7.09M | ||
| Total Assets | 1.64B | ||
| Total Debt | 752.53M | ||
| Current Liabilities | 268.49M | ||
| Debt Non-Current | 752.53M | ||
| Total Liabilities | 1.04B | ||
| Accumulated Retained Earnings (Deficit) | -1.05B | ||
| Shareholders Equity | 604.08M | ||
| Shareholders Equity (USD) | 604.08M | ||
| Assets Non-Current | 493.94M | ||
| Total Debt (USD) | 752.53M | ||
| Deferred Revenue | 31.35M | ||
| Inventory | 223.46M | ||
| Liabilities Non-Current | 767.05M | ||
| Trade and Non-Trade Payables | 213.69M | ||
| Tax Assets | 343.43M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 53.00K | ||
| Net Cash Flow from Financing | 85.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 40.38M | ||
| Capital Expenditure | -293.00K | ||
| Issuance (Purchase) of Equity Shares | 85.00K | ||
| Net Cash Flow from Investing | 1.03M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 1.32M | ||
| Net Cash Flow from Operations | 39.26M | ||
| Share Based Compensation | 27.88M | ||